Adipose Morphology: a Critical Factor in Regulation of Human Metabolic Diseases and Adipose Tissue Dysfunction

被引:0
|
作者
Fangcen Liu
Jielei He
Hongdong Wang
Dalong Zhu
Yan Bi
机构
[1] Nanjing Medical University,Department of Endocrinology, Nanjing Drum Tower Hospital Clinical College
[2] The Affiliated Hospital of Nanjing University Medical School,Department of Endocrinology, Nanjing Drum Tower Hospital
来源
Obesity Surgery | 2020年 / 30卷
关键词
Adipocyte hypertrophy; Obesity; Insulin resistance; Adipose dysfunction;
D O I
暂无
中图分类号
学科分类号
摘要
Emerging evidence highlights that dysfunction of adipose tissue contributes to impaired insulin sensitivity and systemic metabolic deterioration in obese state. Of note, adipocyte hypertrophy serves as a critical event which associates closely with adipose dysfunction. An increase in cell size exacerbates hypoxia and inflammation as well as excessive collagen deposition, finally leading to metabolic dysregulation. Specific mechanisms of adipocyte hypertrophy include dysregulated differentiation and maturation of preadipocytes, enlargement of lipid droplets, and abnormal adipocyte osmolarity sensors. Also, weight loss therapies exert profound influence on adipocyte size. Here, we summarize the critical role of adipocyte hypertrophy in the development of metabolic disturbances. Future studies are required to establish a standard criterion of size measurement to better clarify the impact of adipocyte hypertrophy on changes in metabolic homeostasis.
引用
收藏
页码:5086 / 5100
页数:14
相关论文
共 50 条
  • [1] Adipose Morphology: a Critical Factor in Regulation of Human Metabolic Diseases and Adipose Tissue Dysfunction
    Liu, Fangcen
    He, Jielei
    Wang, Hongdong
    Zhu, Dalong
    Bi, Yan
    OBESITY SURGERY, 2020, 30 (12) : 5086 - 5100
  • [2] Adipose tissue dysfunction contributes to obesity related metabolic diseases
    Blueher, Matthias
    BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2013, 27 (02) : 163 - 177
  • [3] Circadian Dysfunction in Adipose Tissue: Chronotherapy in Metabolic Diseases
    Civelek, Erkan
    Civelek, Dilek Ozturk
    Akyel, Yasemin Kubra
    Durman, Deniz Kaleli
    Okyar, Alper
    BIOLOGY-BASEL, 2023, 12 (08):
  • [4] The Transcription Factor HOXA5: Novel Insights into Metabolic Diseases and Adipose Tissue Dysfunction
    Parrillo, Luca
    Spinelli, Rosa
    Longo, Michele
    Zatterale, Federica
    Santamaria, Gianluca
    Leone, Alessia
    Campitelli, Michele
    Raciti, Gregory Alexander
    Beguinot, Francesco
    CELLS, 2023, 12 (16)
  • [5] Adipose tissue inflammation and metabolic dysfunction in obesity
    Kawai, Tatsuo
    Autieri, Michael, V
    Scalia, Rosario
    AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2021, 320 (03): : C375 - C391
  • [6] Adipose Tissue Dysfunction: Impact on Metabolic Changes?
    Silva Morais, Jennifer Beatriz
    da Silva Dias, Thaline Millany
    Pereira Cardoso, Bruna Emanuele
    Sousa, Mickael de Paiva
    Visgueira de Sousa, Thayanne Gabryelle
    Cardoso de Araujo, Diana Stefany
    Marreiro, Dilina do Nascimento
    HORMONE AND METABOLIC RESEARCH, 2022, 54 (12) : 785 - 794
  • [7] Epicardial adipose tissue in endocrine and metabolic diseases
    Iacobellis, Gianluca
    ENDOCRINE, 2014, 46 (01) : 8 - 15
  • [8] Insulin resistance in adipose tissue and metabolic diseases
    Imi, Yukiko
    Ogawa, Wataru
    Hosooka, Tetsuya
    DIABETOLOGY INTERNATIONAL, 2023, 14 (02) : 119 - 124
  • [9] Adipocyte size as a determinant of metabolic disease and adipose tissue dysfunction
    Laforest, Sofia
    Labrecque, Jennifer
    Michaud, Andreanne
    Cianflone, Katherine
    Tchernof, Andre
    CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES, 2015, 52 (06) : 301 - 313
  • [10] Epigenetic regulation of white adipose tissue in the onset of obesity and metabolic diseases
    Castellano-Castillo, Daniel
    Ramos-Molina, Bruno
    Cardona, Fernando
    Queipo-Ortuno, Maria Isabel
    OBESITY REVIEWS, 2020, 21 (11)